BioLife Solutions Q1 2026 Earnings EPS Slightly Misses Estimates Stock Declines Cencora COR Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Resilient Operations ALOY Q1 2024 Earnings EPS Misses Estimates Significantly Stock Rises Unexpectedly Nathans Famous Inc NATH Q4 2024 Earnings EPS of 096 Despite Quiet Quarter Stock Edges Lower Supernus Pharmaceuticals SUPN Q1 2026 Earnings EPS Surges Past Expectations but Stock Retreats UTSI Q4 2019 Earnings EPS Misses Estimates by Wide Margin Revenue Not Disclosed Genpact G Q1 2026 Earnings EPS Beat Highlights Resilient Operations Amid Market Caution AGX Q1 2026 Earnings Massive EPS Beat Surprises Market NG Q1 2026 Earnings Narrowed Loss Beat Estimates as Donlin Gold Project Advances FSLR Q1 2026 Earnings EPS Beat Bolstered by Strong Operating Performance and Demand Tailwinds VLTO Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher APG Q1 2026 Earnings EPS Beats Estimates Amid Unclear Revenue Picture